Please login to the form below

Not currently logged in


This page shows the latest Merck news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

The proceeds will fund phase III trials of its overactive bladder treatment candidate vibegron, which it in-licensed last year from Merck &Co.

Latest news

More from news
Approximately 358 fully matching, plus 1,052 partially matching documents found.

Latest Intelligence

  • Advancing women in healthcare Advancing women in healthcare

    Taking on the mantle of HBA’s Woman of the Year 2018 is Julie Gerberding, Merck &Co’s chief patient officer, and head of global public policy and population health. ... She joined Merck &Co in 2009 and sees her role in promoting vaccines and

  • 30 Women Leaders in UK Healthcare

    2. Louise Houson, MSD UK and Ireland General Manager. L ouise Houson is the first ever woman leader of MSD in the UK and Ireland (known as Merck Inc in North

  • Implementing eHealth innovation Implementing eHealth innovation

    Innovation has driven Merck’s growth and performance to its 350-year celebration in 2018. ... is head of the global business franchise, general medicine and endocrinology at Merck KGaA.

  • The good, the bad and the ugly The good, the bad and the ugly

    Beyond Pfizer, the biggest positive movers in the top 20 include Shire, Bayer and Merck &Co. ... Merck &Co grew cardiovascular revenues by 130%, while GSK enjoyed a 214% uplift, mainly due to its PAH treatment Volibris.

  • The bulk of pharma digital spend fails to alter industry’s greenhorn status The bulk of pharma digital spend fails to alter industry’s greenhorn status

    Pfizer, AstraZeneca and Merck fare well on the Cx scores, largely due to the relevance of content provided to HCPs on the go, while Pfizer, Amgen and AZ outscored others on

More from intelligence
Approximately 7 fully matching, plus 112 partially matching documents found.

Latest appointments

More from appointments
Approximately 38 fully matching, plus 133 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    Marketing strategy in complex environments. Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through

  • Personalizing customer engagement in pharma

    Personalizing customer engagement in pharma. Barcelona eyeforpharma 2015 highlights: Philippe Kirby, Merck, David Hunt, Havas LYNX, and Richie Bavasso, Agnitio share their views on digital pharma trends. ... Summary/transcript. Barcelona eyeforpharma

  • Novartis CEO on patient value

    Including:. · How GSK, Pfizer and Merck are feeding patient voice, customer insight and point of value into their service strategies for user uplift. · ... You can see the full brochure which drills down in to each session here: . With attendees from

  • Active Life Ahead: Brand Campaign

    Client: Merck Sharp &Dohme.

  • Active Life Ahead: Press Advert

    Client: Merck Sharp &Dohme.

More from PMHub
Approximately 1 fully matching, plus 38 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare through effective collaboration. Making work to feel proud of.

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....